-transparent.png){kind=logo}
1. Inhibitors of neutral endopeptidase EC.3.4.24.11 (NEP) have been shown to attenuate the hypertensive effect of big-endothelin-1 (BET-1) in rats. To determine whether NEP converts BET-1 to endothelin-1 (ET-1), the effect of a recombinant NEP (rNEP) on BET-1 and on ET-1 was assessed in vitro. 2. Incubation of [125I]-ET-1 with 1 microgram ml-1 of rNEP resulted in degradation of the peptide within minutes. Increase in the amount of rNEP to 10 micrograms ml-1 led to total cleavage of [125I]-ET-1 within seconds. 3. Phosphoramidon (10 microM) or SQ-28,603 (100 microM) totally suppressed the degradation of [125I]-ET-1 by rNEP. 4. The degradation of [125I]-BET-1 by either 1 or 10 micrograms ml-1 of rNEP was much slower than that of [125I]-ET-1. Again, both phosphoramidon and SQ 28,603 protected the peptide from degradation. 5. Intact [125I]-ET-1 was not observed when [125I]-BET-1 was incubated with rNEP. 6. These data show that neutral endopeptidase EC.3.4.24.11 is not an endothelin converting enzyme.
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
May 1991,
Immunology letters,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
April 1997,
Journal of enzyme inhibition,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
September 1999,
Proceedings of the National Academy of Sciences of the United States of America,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
October 1995,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
June 1992,
Hypertension (Dallas, Tex. : 1979),
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
September 1991,
The Biochemical journal,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
April 1993,
The American journal of physiology,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
May 1993,
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
June 2006,
American journal of physiology. Renal physiology,
Z A Abassi, and
E Golomb, and
R Bridenbaugh, and
H R Keiser
February 1989,
Biochemical and biophysical research communications,
